deltatrials
Completed NCT04611893

Monitoring of NOAC Therapy: Standardizing Reference Intervals

Sponsor: Chinese University of Hong Kong

Conditions Ischemic Ischemic Stroke Stroke Syndrome Stroke, Acute
Updated 10 times since 2020 Last updated: Feb 21, 2026 Started: Nov 5, 2020 Primary completion: Jun 30, 2025 Completion: Jun 30, 2025

Listed as NCT04611893, this observational or N/A phase trial focuses on Ischemic and Ischemic Stroke and remains completed. Sponsored by Chinese University of Hong Kong, it has been updated 10 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

10 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed

    Status: Recruiting → Completed

  2. Jan 2025 — Feb 2026 [monthly]

    Recruiting

  3. Sep 2024 — Jan 2025 [monthly]

    Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  5. Feb 2024 — Jul 2024 [monthly]

    Recruiting

▶ Show 5 earlier versions

  1. Mar 2023 — Feb 2024 [monthly]

    Recruiting

  2. Jun 2022 — Mar 2023 [monthly]

    Recruiting

  3. Dec 2021 — Jun 2022 [monthly]

    Recruiting

  4. Jan 2021 — Dec 2021 [monthly]

    Recruiting

  5. Dec 2020 — Jan 2021 [monthly]

    Recruiting

    First recorded

Nov 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chinese University of Hong Kong
Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Hong Kong, Hong Kong